Act Advisors, Llc. Heron Therapeutics, Inc. Transaction History
Act Advisors, Llc.
- $212 Million
- Q2 2025
A detailed history of Act Advisors, Llc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Act Advisors, Llc. holds 25,655 shares of HRTX stock, worth $47,718. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,655
Previous 25,581
0.29%
Holding current value
$47,718
Previous $57,000
7.02%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
184Shares Held
126MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$49.7 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$15.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$14.6 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $221M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...